Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by langostaon May 21, 2018 3:40pm
111 Views
Post# 28060618

RE:RE:RE:Right to Try

RE:RE:RE:Right to TryIf 38 states already have 'right to try' I guess our company is still well under the radar in the U.S. Would the inclusion of the other 12 states make much of a difference? I suppose it would depend on how populous the 12 were. We are really still  at  begining steps in our progress. Do the 38 RTT follow the same rules? There might be a fair bit of confusion with 38 States legislative assemblies doing up there own individual rules and regs. If the senate passes the legislation does that mean all states must comply with the Federal rules? i.e. taking precedence over state rules. One of the major items that could increase the number of participants dramatically is cutting the FDA out of the RTT loop. With 'expanded access' giving only a 10% approval from the FDA that cautionary step is removed and it will be a strictly, "be it on your own head mate" type of deal. I personally don't see the problem here if I was terminally ill, but then I guess it is a, 'you have to be there situation'.
Let's get our own phase 1 trials over with then if RTT passes we can participate.
The fact that the Koch Bros. approve of this Bill is the only thing that makes me look over my back and think, 'what am I missing here'.    
Bullboard Posts